Secukinumab treatment for ankylosing spondylitis and concomitant Huntington's disease: real-world experience

被引：0
|
作者：
Gokten, D. Bulut [1 ]
Mercan, R. [1 ]
机构：
[1] Tekirdag Namik Kemal Univ, Tekirdag, Turkiye
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2024年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：767 / 767
页数：1
相关论文
共 50 条
  • [21] REAL-WORLD CHARACTERISTICS OF ANKYLOSING SPONDYLITIS PATIENTS WHO STARTED TREATMENT WITH SECUKINUMAB: NATIONWIDE RESULTS FROM THE REUMA.PT REGISTRY
    Santos, H.
    Laires, P. A.
    Garcia, S.
    Nero, P.
    Pestana, J.
    Martins-Martinho, J.
    Silva, A. B.
    Rodrigues, J.
    Sequeira, G.
    Costa, E.
    Santos, F. C.
    Furtado, C.
    Santos, B.
    Raposo, A.
    Saraiva, L.
    Samoes, B.
    Barcelos, F.
    Santos, M. J.
    Tavares-Costa, J.
    VALUE IN HEALTH, 2020, 23 : S593 - S593
  • [22] Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary
    Fonti, G. L.
    Chimenti, M. S.
    Greco, E.
    Boffa, L.
    Conigliaro, P.
    Triggianese, P.
    Perricone, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (01) : 223 - 223
  • [23] Safety of secukinumab for the treatment of active ankylosing spondylitis
    Loricera, Javier
    Galindez-Aguirregoikoa, Eva
    Blanco, Ricardo
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 627 - 634
  • [24] Secukinumab Dose Escalation for the Treatment of Ankylosing Spondylitis in Canada: Retrospective Analysis Using Real-World Data from the XPOSE Patient Support Program
    Aydin, Sibel
    Inman, Robert
    Masetto, Ariel
    Wade, John
    Wang, Ching-An
    Shi, Yulin
    Tian, Haijun
    Leclerc, Patrick
    Parent, Sophie
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1115 - 1116
  • [25] Geographic Variations in Diagnosis and Treatment of Ankylosing Spondylitis in the United States: A Real-World Study
    Atul Deodhar
    Denise Kruzikas
    Lili Zhou
    Ana Biljan
    Christopher D. Saffore
    Rheumatology and Therapy, 2022, 9 : 447 - 463
  • [26] Geographic Variations in Diagnosis and Treatment of Ankylosing Spondylitis in the United States: A Real-World Study
    Deodhar, Atul
    Kruzikas, Denise
    Zhou, Lili
    Biljan, Ana
    Saffore, Christopher D.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 447 - 463
  • [27] Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary
    Macaluso, F.
    Guggino, G.
    Ciccia, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (01) : 224 - 224
  • [28] Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease
    Chugh, Rishika
    Braga-Neto, Manuel B.
    Fredrick, Thomas W.
    Ramos, Guilherme P.
    Terdiman, Jonathan
    El-Nachef, Najwa
    Loftus, Edward, V
    Mahadevan, Uma
    Kane, Sunanda, V
    JOURNAL OF CROHNS & COLITIS, 2022, : 504 - 512
  • [29] Real-World Use of Secukinumab Among Biologic-NaiVe and Biologic-Experienced Patients with Ankylosing Spondylitis in the United States
    Oelke, Kurt R.
    Garg, Rahul
    Li, Yunfeng
    Liu, Xing
    Zhou, Huanxue
    Park, Yujin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] SECUKINUMAB EFFECTIVENESS AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY IN THE REAL-WORLD SETTING
    Gaffney, Karl
    Gullick, Nicola
    Kiltz, Uta
    Sfikakis, Petros
    Theodoridou, Athina
    Brandt-Juergens, Jan
    Lespessailles, Eric
    Perella, Chiara
    Pournara, Effie
    Schulz, Barbara
    Veit, Justyna
    RHEUMATOLOGY, 2021, 60 : 99 - +
12345